Preserving the tumor microenvironment
Elephas has developed a platform that utilizes fresh patient biopsies to preserve the tumor microenvironment (TME) for evaluation of immunotherapy response. The CybridPrep process prepares these biopsies using proprietary instruments to cut and encapsulate them before assessment on the Elephas platform.
The tumor microenvironment includes various cell types in a distinct extracellular matrix. The interaction among tumor, noncancerous, and immune cells can create an immunosuppressive environment that promotes tumor progression.
The complex interactions within the tumor microenvironment impact tumor formation, drug resistance, and immunotherapy response. These interactions are essential for understanding immunotherapy activity and how it will translate to patient response. Without preserving the tumor microenvironment, response prediction becomes a challenge.
Preserving the tumor microenvironment
Assessing the tumor with advanced imaging
Delivering data via secure, cloud-based portal
The unique CybridPrep process prepares the live biopsy for baseline and immunotherapy response assessment through proprietary cutting and encapsulation methods. These tools protect the native 3-dimensional cellular architecture and tumor microenvironment to enable the second step in the process, CybridScope.
Read the latest data behind our platform.
Stay up to date on our advanced imaging platform.